Effect of staurosporine-induced apoptosis on endothelial nitric oxide synthase in transfected COS-7 cells and primary endothelial cells

Cell Death and Differentiation

Volumn 13, Issue 4, 2006, Pages 597-606

  Tesauro, M ^a,b   Thompson, W C ^a   Moss, J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b University of Rome 'or Vergata'   (Italy)

Author keywords

Apoptosis; Caspases; Endothelial nitric oxide synthase; eNOS; Nitric oxide

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CALMODULIN; CASPASE 3; CASPASE 6; CASPASE 7; CYSTEINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; PROTEIN KINASE INHIBITOR; RECOMBINANT ENZYME; SERINE; STAUROSPORINE; THREONINE;

ANIMAL CELL; AORTA; APOPTOSIS; ARTICLE; CELL STRAIN COS7; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; APOPTOSIS; CALMODULIN; CASPASE 3; CASPASE 6; CASPASE 7; CASPASES; CATTLE; CERCOPITHECUS AETHIOPS; COS CELLS; CYSTEINE PROTEINASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; NITRIC OXIDE SYNTHASE TYPE III; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN BINDING; PROTEIN KINASE INHIBITORS; STAUROSPORINE; TIME FACTORS; TRANSFECTION;

ANIMALIA; BOVINAE;

EID: 33644963540     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401770     Document Type: Article

References (29)

1. Hengartner MO (2000) The biochemistry of apoptosis. Nature 407: 770-776
2. Meier P, Finch A and Evan G (2000) Apoptosis in development. Nature 407: 796-801
3. Ameisen JC (2002) On the origin, evolution and nature of programmed cell death: A timeline of four billion years. Cell Death Diffr. 9: 367-393
4. Nicholson DW and Thornberry NA (2003) Apoptosis: Life and death decisions. Science 299: 214-215
5. Shi Y (2002) Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell 9: 459-470
6. Nicholson DW and Thornberry NA (1997) Caspases: Killer proteases. Trends in Biol. Sci. 22: 299-306
7. Cohen GM (1997) Caspases: The executioners of apoptosis. Biochem. J. 326: 1-16
8. Dragovich T, Rudin CM and Thompson CB (1998) Signal transduction pathways that regulate cell survival and cell death. Oncogene 17: 3207-3213
9. Lopez E and Ferrer I (2000) Staurosporine- and H-7-induced cell death in SH-SY5Y neurosblastoma cells is associated with caspase-2 and caspase-3 activation. Mol. Brain Res. 85: 61-67
10. Feng G and Kaplowitz N (2002) Mechanisms of staurosporine-induced apoptosis in murine hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 282: G825-G834
11. Thornberry NA and Lazebnik Y (1998) Caspases: Enemies within. Science 281: 1312-1316
12. Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi X M, Tsui LC and Schappert KT (1993) Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J. Biol. Chem. 268: 17478-17488
13. Moncada S, Higgs A and Furchgott R (1997) International Union of Pharmacology Nomenclature in Nitric Oxide Research. Pharmacol. Rev. 49: 137-142
14. Michel T and Feron O (1997) Nitric oxide syntheses: Which, where, how, and why? J. Clin. Invest. 100: 2146-2152
15. Raman CS, Li H, Martasek P, Krai V, Masters BS and Poulos TL (1998) Crystal structure of constitutive endothelial nitric oxide synthase: A paradigm for pterin function involving a novel metal center. Cell 95: 939-950
16. Fleming I and Busse R (2003) Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284: R1-R12
17. Wu KK (2002) Regulation of endothelial nitric oxide synthase activity and gene expression. Ann. NY Acad Sci. 962: 122-130
18. Kim PK, Zamora R, Petrosko P and Billiar TR (2001) The regulatory role of nitric oxide in apoptosis. Int. Immunopharmacol. 1: 1421-1441
19. Kim PK, Kwon YG, Chung HT and Kim YM (2002) Regulation of caspases by nitric oxide. Ann. NY Acad. Sci. 962: 42-52
20. Li J, Billiar TR, Talanian RV and Kim YM (1997) Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem. Biophys. Res. Commun. 240: 419-424
21. Garcia-Calvo M, Peterson EP, Leiting B, Ruel R, Nicholson DW and Thornberry NA (1998) Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. 273: 32608-32613
22. Dimmeler S, Haendeler J, Nehls M and Zeiher AM (1997) Suppression of apoptosis by nitric oxide via inhibition of interleukin-1-converting enzyme (ICE)-like and cytsteine protease (CPP)-32-like proteases. J. Exp. Med. 185: 601-607
23. Rossig L, Fichtlscherer B, Breitschopf K, Haendeler J, Zeiher AM, Mulsch A and Dimmeler S (1999) Nitric oxide inhibits caspase-3 by S-nitrosylation in vivo. J. Biol. Chem. 274: 6823-6826
24. Melino G, Bernassola F, Knight RA, Corasanti MT, Nistico G and Finnazzi-Agro A (1997) S-nitrosylation regulates apoptosis. Nature 388: 432-433
25. Tricot O, Mallat Z, Heymes C, Belmin J, Leseche G and Tedgui A (2000) Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques. Circulation 101: 2450-2453
26. Hoffman J, Haendeler J, Aicher A, Rossig L, Vasa M, Zeiher AM and Dimmeler S (2001) Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli. Circ. Res. 89: 709-715
27. Harrison DG (1997) Cellular and molecular mechanisms of endothelial cell dysfunction. J. Clin. Invest. 100: 2153-2157
28. A receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein deficient mice. Proc. Natl. Acad. Sci. USA 95: 14367-14372
29. Lee CM, Robinson LJ and Michel T (1995) Oligomerization of endothelial nitric oxide synthase. Evidence for a dominant negative effect of truncation mutants. J. Biol. Chem. 270: 27403-27406